Grand Rounds | Aging & Dementia

Speaker: Suzanne Schindler Grand Rounds will be in person and participants are invited to watch the lecture at 7:45 a.m. in either the Connor or Moore Auditoriums. A zoom link will be emailed for participants not able to attend in person. This link is a recurring meeting link for all Neurology Grand Rounds. All lectures […]

Blood-based biomarkers for treatment monitoring in Alzheimer’s disease (Links to an external site)

Suzanne Schindler

Suzanne Schindler, MD, PhD, Washington University in St. Louis School of Medicine, St. Louis, MO, discusses the promise of blood-based biomarkers for treatment monitoring. Data has been presented on plasma phosphorylated-tau 217 (p-tau217) as a method to monitor the effects of lecanemab and donanemab. This research is investigating if medication discontinuation is feasible if p-tau217 […]

Prioritizing diversity in Alzheimer’s disease biomarker studies (Links to an external site)

Suzanne Schindler, MD, PhD, on VJ Dementia

Suzanne Schindler, MD, PhD, Washington University in St. Louis School of Medicine, St. Louis, MO, gives insight into the need for more diverse cohorts to improve our understanding of the impact of sex, age, and race on biomarker levels and trajectories in Alzheimer’s disease. While efforts to study racial and ethnic minority populations have improved, […]

Recent Graduates

Class of 2024 Name Position Location Busranur Agac Neuroimmunology and NeuroinfectiousDiseases Fellow National Institutes of Health (NIH) Ravi Chopra Neuromuscular Fellow Washington University in St. Louis Jesse Crayle Neuromuscular Fellow Washington University in St. Louis Maren Gregersen Dementia Fellow Washington University in St. Louis Tina Kiguradze Epilepsy Fellow Washington University in St. Louis Gabrielle Lindley […]

How St. Louis researchers are seeking ways to combat Alzheimer’s and dementia (Links to an external site)

ILLUSTRATION BY SWILLKLITCH / ISTOCK / GETTY IMAGES PLUS

Alzheimer’s disease starts forming in the brains of unsuspecting individuals about 20 years before traditional telltale signs become noticeable. No cure exists for the progressive, fatal disease, but St. Louis medical researchers are studying tools and potential drugs that can detect and treat Alzheimer’s in its early stages. “The tests are getting better and better,” […]